Showing results (1321-1330 of 6,882) with videos related to
Sort By:
Pageof 689
Leukemia Research|May 19, 2026
Economic burden of leukemia diagnosis and treatment in South Africa: A retrospective cost of illness analysisRochelle Woudberg, Sarah Muriel Meiring, Edina SinanovicLeukemia Research|December 23, 2014
Correlation between FLT3-ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemiasCarolina Pereira Souza Melo, Catharina Brant Campos, Álvaro Pimenta Dutra, et al.Leukemia Research|April 14, 2026
Efficacy of hypomethylating agents in combination with venetoclax in relapsed/refractory acute myeloid leukemia: A systematic review and meta-analysisBrittany Salter, Sarah Ge, Tobias Berg, et al.Leukemia Research|May 6, 2026
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature reviewDeniz Özmen, Derya Deniz Kürekçi, Vildan Özkocaman, et al.Leukemia Research|May 12, 2026
Clinical and immune features associated with chromosome 13q deletion and PRKCSH downregulation in newly diagnosed multiple myelomaJiayuan Li, Zuxi Feng, Wen Yang, et al.Leukemia Research|February 21, 2026
Outcomes of patients with R/R FLT3mut+ AML treated with maintenance gilteritinib therapy after hematopoietic stem cell transplantationHsin-An Hou, Bartlomiej Getta, Jae-Sook Ahn, et al.Leukemia Research|March 4, 2026
Measurable residual disease detection in acute leukemia: Technological advances and clinical translationMeixin Wang, Jianfang LiLeukemia Research|May 27, 2023
Enhancing morphological analysis of peripheral blood cells in chronic lymphocytic leukemia with an artificial intelligence-based toolYan Wang, Hailing Liu, Hui Wang, et al.Leukemia Research|June 1, 1997
Effects of retinoic acid on a new human erythromegakaryocytic cell line AP-217P Mossuz, M H Prandini, D Leroux, et al.Leukemia Research|July 19, 2023
Changing frontline AML treatment patterns from 2013 to 2022Joseph M Brandwein, Kurt Ebeling, Lei Ding, et al.Pageof 689